Jennison Associates LLC Protagonist Therapeutics, Inc Transaction History

Jennison Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	BUY	$10.78 - $25.38 $4.62 Million - $10.9 Million	428,938 New	428,938 $9.87 Million
Q4 2018 Feb 06, 2019	SELL	$6.3 - $10.44 $2.2 Million - $3.65 Million	-349,697 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$6.82 - $11.26 $2.38 Million - $3.94 Million	349,697 New	349,697 $3.6 Million
Q1 2018 Apr 20, 2018	SELL	$8.46 - $23.08 $846,000 - $2.31 Million	-100,000 Closed	0 $0
Q4 2017 Jan 25, 2018	BUY	$14.47 - $20.8 $1.45 Million - $2.08 Million	100,000	100,000 $2.08 Million

247

56.4M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.